United States Patent and Trademark Office (USPTO) Public Awareness campaign strategy on the dangers of counterfeit substances or devices
Open — responses due 16 Nov 2026 (2 days left) · Unrestricted (full and open) · U.S. Patent and Trademark Office, DOC · NAICS 541820 · Solicitation 140-0176
Get the AI read before you spend a day on this package. FedSift pulls out the deal-breakers and key risks, each quoted from the document. Free, no account.
Before you spend a day on this package: FedSift reads every document and pulls out what is being bought, the deal-breakers and the key risks — each quoted from the page it came from. Free, no account needed. The result is shared, so the next reader gets it instantly. With a free account it also builds the full compliance matrix.
Track this solicitation
We'll email you if the response deadline moves, an amendment posts, or new documents are added. It closes 16 November 2026. No account needed — one email, unsubscribe in a click.
Description
Questions/Answers posted as of November 12, 2026 at 9:50 AM. THIS IS A PTAG SOURCES SOUGHT REQUEST FOR INFORMATION (RFI) ONLY. In accordance with the Patent and Trademark Office Efficiency Act (PTOEA), 35 U.S.C. § 2(b)(4)(A), this Sources Sought Notice Request for Information) (RFI) is strictly for market research ONLY. It is for informational and planning purposes and shall NOT be construed as a solicitation or as an obligation or commitment by the Government at this time. This RFI is being made available under NAICS 541820 - Public Relations Agencies. This effort is for campaign services to support a nationwide public awareness campaign to highlight the dangers of counterfeit pharmaceuticals and medical devices. The USPTO is seeking information from qualified vendors regarding capabilities and relevant experience to support potential public relations services to create and execute a nationwide public awareness campaign consisting of media relations, videos, and other creative communications deliverables including a microsite and social media campaign to highlight the dangers of counterfeit pharmaceuticals and medical devices that are falsely represented as products made or distributed by real pharmaceutical and medical device companies. Submission Instructions: Questions due: no later than October 26, 2026 at 1pm ET RFI Response Due Date: November 16, 2026 10am ET All details are located within the PDF attachment.
Version history
SAM.gov has posted 4 notices under solicitation 140-0176, oldest first.
FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.
Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.
